Charles W. Nager

Charles W. Nager

Auto-generated profile, based on publicly available information

Charles W. Nager

UC San Diego Health System, La Jolla, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
CNCharles W. Nager
Charles W. Nager
LBLinda Brubaker
Linda Brubaker
HLHeather J. Litman
Heather J. Litman
HZHalina M. Zyczynski
Halina M. Zyczynski
RVR. Edward Varner
R. Edward Varner
EGE. Ann Gormley
E. Ann Gormley
Urodynamic studies are commonly performed in women before surgery for stress urinary incontinence, but there is no good evidence that they improve outcomes. We performed a multicenter, randomized, noninferiority trial involving women with uncomplicated, demonstrable stress urinary incontinence to compare outcomes after preoperative office evaluation and urodynamic tests or evaluation only. The primary outcome was treatment success at 12 months, defined as a reduction in the score on the Urogenital Distress Inventory of 70% or more and a response of “much better” or “very much better” on the Patient Global Impression of Improvement. The predetermined noninferiority margin was 11 percentage points. A total of 630 women were randomly assigned to undergo office evaluation with urodynamic tests or evaluation only (315 per group); the proportion in whom treatment was successful was 76.9% in the urodynamic-testing group versus 77.2% in the evaluation-only group (difference, −0.3 percentage points; 95% confidence interval, −7.5 to 6.9), which was consistent with noninferiority. There were no significant between-group differences in secondary measures of incontinence severity, quality of life, patient satisfaction, rates of positive provocative stress tests, voiding dysfunction, or adverse events. Women who underwent urodynamic tests were significantly less likely to receive a diagnosis of overactive bladder and more likely to receive a diagnosis of voiding-phase dysfunction, but these changes did not lead to significant between-group differences in treatment selection or outcomes. For women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone was not inferior to evaluation with urodynamic testing for outcomes at 1 year. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT00803959.)

23 October 2004 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
JTJasmine S. Tan
Jasmine S. Tan
ELEmily S. Lukacz
Emily S. Lukacz
SMShawn A. Menefee
Shawn A. Menefee
CPCurt R. Powell
Curt R. Powell
CNCharles W. Nager
Charles W. Nager
SCSan Diego Pelvic Floor Consortium
San Diego Pelvic Floor Consortium

1 April 2008 in Journal of Urology
Verified
Journal Article
Closed access
CNCharles W. Nager
Charles W. Nager
MFMaryPat FitzGerald
MaryPat FitzGerald
SKStephen R. Kraus
Stephen R. Kraus
TCToby C. Chai
Toby C. Chai
HZHalina Zyczynski
Halina Zyczynski
UNUrinary Incontinence Treatment Network
Urinary Incontinence Treatment Network
We determined the prognostic value of preoperative urodynamic results in patients with stress urinary incontinence. In a 9-center surgical trial, women with stress urinary incontinence were randomized to a Burch or pubovaginal sling procedure. Women were eligible for the study if they had predominant stress urinary incontinence symptoms, a positive cough stress test, a bladder capacity more than 200 ml and urethral hypermobility. Preoperative free uroflowmetry, filling cystometry and pressure flow studies were performed in all. Overall treatment success required a negative pad test, no urinary incontinence on a 3-day diary, a negative stress test, no self-reported stress urinary incontinence symptoms and no re-treatment for stress urinary incontinence. Stress specific success required all of the last 3 criteria. We examined urodynamic measures, and whether the presence of urodynamic stress incontinence, the presence of detrusor overactivity and Valsalva leak point pressure would predict surgical success. Subjects with urodynamic stress incontinence had a 2-fold greater odds of overall success when compared with the No urodynamic stress incontinence group, but this trend did not quite reach statistical significance (OR 2.26; 95% C.I. 0.99, 5.17). Odds of stress specific success did not differ by urodynamic stress incontinence status. Subjects with detrusor overactivity did not have significantly worse success rates. Stratifying by treatment group, there was no difference in mean Valsalva leak point pressure values between surgical successes and failures. We found a nearly statistically significant trend that women with urodynamic stress incontinence are twice as likely to have a successful overall outcome from surgical management of stress urinary incontinence as women without urodynamic stress incontinence. The level of Valsalva leak point pressure and the presence of detrusor overactivity do not predict the success outcomes after the Burch or autologous fascia sling procedures in women with pure or predominant stress urinary incontinence. The impact of urodynamic studies on surgical outcomes needs further investigation.

17 September 2019 in JAMA
Verified
Journal Article
Open access
PDF file
CNCharles W. Nager
Charles W. Nager
AVAnthony G. Visco
Anthony G. Visco
Holly E RichterHolly E Richter
Holly E Richter
CRCharles R. Rardin
Charles R. Rardin
RRRebecca G. Rogers
Rebecca G. Rogers
NNNichd Pelvic Floor Disorders Network
Nichd Pelvic Floor Disorders Network
Surgery for uterovaginal prolapse is common. In an analysis of a US database from 2007 to 2011, an estimated 13% of women underwent pelvic organ prolapse surgery by the age of 80 years.1 In a 2016 British Society of Urogynecology survey with a 42% response rate, 75% of 212 urogynecology surgeons considered vaginal hysterectomy the procedure of choice for women with uterovaginal prolapse.2 Uterine-sparing suspension techniques, known as hysteropexy, are increasing in usage, but in a US inpatient hospital database from 2002 to 2012, hysteropexy accounted for 5% of uterovaginal prolapse procedures and hysterectomies were performed 8 times more often.3 In a survey of 244 US women with an 89% response rate, 36% preferred uterine preservation, 20% preferred hysterectomy, and 44% were ambivalent assuming comparable outcomes at the time of uterovaginal prolapse repair.4 The broad range of age, goals, and expectations of women who seek prolapse surgical correction and the elective nature of treatment are ideally weighed in a shared decision-making process grounded in sound scientific evidence.

1 August 2011 in Journal of Urology
Verified
Journal Article
Closed access
CNCharles W. Nager
Charles W. Nager
LSLarry Sirls
Larry Sirls
HLHeather J. Litman
Heather J. Litman
Holly E RichterHolly E Richter
Holly E Richter
INIngrid Nygaard
Ingrid Nygaard
UNUrinary Incontinence Treatment Network
Urinary Incontinence Treatment Network
We determined whether baseline urodynamic study variables predict failure after mid urethral sling surgery. Preoperative urodynamic study variables and postoperative continence status were analyzed in women participating in a randomized trial comparing retropubic to transobturator mid urethral sling. Objective failure was defined by positive standardized stress test, 15 ml or greater on 24-hour pad test, or re-treatment for stress urinary incontinence. Subjective failure criteria were self-reported stress symptoms, leakage on 3-day diary or re-treatment for stress urinary incontinence. Logistic regression was used to assess associations between covariates and failure controlling for treatment group and clinical variables. Receiver operator curves were constructed for relationships between objective failure and measures of urethral function. Objective continence outcomes were available at 12 months for 565 of 597 (95%) women. Treatment failed in 260 women (245 by subjective criteria, 124 by objective criteria). No urodynamic variable was significantly associated with subjective failure on multivariate analysis. Valsalva leak point pressure, maximum urethral closure pressure and urodynamic stress incontinence were the only urodynamic variables consistently associated with objective failure on multivariate analysis. No specific cut point was determined for predicting failure for Valsalva leak point pressure or maximum urethral closure pressure by ROC. The lowest quartile (Valsalva leak point pressure less than 86 cm H2O, maximum urethral closure pressure less than 45 cm H2O) conferred an almost 2-fold increased odds of objective failure regardless of sling route (OR 2.23, 1.20-4.14 for Valsalva leak point pressure and OR 1.88, 1.04-3.41 for maximum urethral closure pressure). Women with a Valsalva leak point pressure or maximum urethral closure pressure in the lowest quartile are nearly 2-fold more likely to experience stress urinary incontinence 1 year after transobturator or retropubic mid urethral sling.

15 February 2005 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
NGNoelani M. Guaderrama
Noelani M. Guaderrama
CNCharles W. Nager
Charles W. Nager
JLJianmin Liu
Jianmin Liu
DPDolores H. Pretorius
Dolores H. Pretorius
RMRavinder K. Mittal
Ravinder K. Mittal